Evidence map›Paper›PMID 30975300›Full record

ArticleJournal of the American College of Cardiology2019

Modulating Adaptive Immunity in Vascular Disease: CD4 to the Fore.

Peter Libby, Andrew I Lichtman

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Journal of the American College of Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Peter LibbyDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Vascular Research Division, Department of Pathology and the Center of Excellence in Vascular Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: plibby@bwh.harvard.edu.
Andrew I LichtmanDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Vascular Research Division, Department of Pathology and the Center of Excellence in Vascular Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Funding

Molecular Determinants of Arterial Remodeling in AtherogenesisR01HL080472 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIBBY, PETER · 2005 to 2018
$5.0M
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and AtherosclerosisR01HL131862 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RODRIGUEZ, ANNABELLE · 2016 to 2019
$3.0M
Protection of the Heart by PD-1 and PD-L1R01HL121363 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LICHTMAN, ANDREW H, SHARPE, ARLENE H. · 2014 to 2017
$1.7M
NHLBI NIH HHS R01 HL080472NHLBI NIH HHS R01 HL121363NHLBI NIH HHS R01 HL131862
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

T-LymphocytesVasculitisAdaptive ImmunityCD28 AntigensHumansSignal TransductionCD28 AntigensCD28giant cell arteritisglycolysisimmunometabolismT cellvasculitis

Identifiers

PMID30975300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.